China is entering a new phase of its cancer epidemic, and a large-scale analysis of global disease data suggests that digestive system cancers now pose a lifetime threat to roughly one in nine people in the country. The study, published in the Chinese Medical Journal on June 3, 2026, estimates that 11.36% of the Chinese population will develop a digestive system cancer during their lifetime, while 8.28% will die from one. The findings offer a perspective that conventional cancer statistics often fail to provide: instead of describing risk at a particular moment or within a single year, lifetime-risk analysis estimates the probability that an individual will experience or die from cancer across the entire course of life.

The research was led by Zhou Maigeng of the National Center for Chronic and Noncommunicable Disease Control and Prevention, China CDC, together with Qian Mao of Shandong University. The investigators used estimates from the Global Burden of Disease Study 2023 to examine digestive cancers nationally and across China’s regions. Their analysis covered the probability of developing and dying from cancers affecting the digestive system, including colorectal, stomach, liver and other gastrointestinal cancers. By translating population-level disease data into an individual-scale measure, the study provides a more accessible way to understand the consequences of demographic aging, changing lifestyles and uneven economic development.

Lifetime risk is not equivalent to a simple addition of annual cancer probabilities. A person’s chance of developing cancer depends on age, sex, competing causes of death and the possibility of developing more than one primary cancer. To address these issues, the researchers applied the Adjusted for Multiple Primaries, or AMP, method. This statistical approach is designed to account for multiple primary cancers in the same individual and to avoid inflating risk estimates when cancers occur at different times. It also incorporates competing risks, recognizing that a person may die from cardiovascular disease, infection, injury or another condition before developing cancer. As a result, the AMP-based estimates are intended to more closely represent the probability faced by a real population rather than a purely theoretical cumulative risk.

The national figures reveal the scale of the challenge. An estimated 11.36% lifetime risk of developing digestive system cancer means that, statistically, approximately one person in every nine could receive such a diagnosis during their lifetime. The estimated lifetime mortality risk of 8.28%, or about one in twelve people, indicates that digestive cancers continue to carry a substantial fatality burden. These numbers should not be interpreted as predictions for any single individual, since personal risk varies according to age, family history, smoking, alcohol consumption, diet, infections, obesity, physical activity, access to screening and treatment, and other factors. They do, however, show how digestive cancers collectively influence population health and longevity.

The pattern of disease is also changing. Colorectal cancer had the highest lifetime incidence risk among the digestive cancers examined, reaching 3.98%. This finding reflects a broader epidemiological transition in China. Stomach and liver cancers have historically played a dominant role in the country’s digestive cancer burden, with risks influenced by factors such as Helicobacter pylori infection, hepatitis B virus infection and environmental exposures. Although these causes remain important, rapid urbanization and economic transformation have altered patterns of food consumption, work and physical activity. Diets higher in processed and fatty foods and lower in fiber, combined with sedentary lifestyles and rising obesity in some populations, are associated with colorectal cancer risk. At the same time, China’s expanding older population is increasing the number of people reaching the ages at which cancer becomes more common.

The study identified a pronounced difference between men and women. Men had an estimated lifetime risk of developing digestive system cancer of 14.45%, substantially higher than the national estimate for women. The researchers’ findings are consistent with the contribution of behavioral exposures that have historically been more prevalent among men, particularly tobacco smoking and alcohol consumption. These exposures can interact with biological susceptibility and other environmental factors to influence cancers of the liver, esophagus, stomach, colorectum and other digestive organs. The sex gap also highlights why prevention strategies must combine population-wide measures with targeted interventions. Reducing tobacco and alcohol use, improving diet and increasing physical activity could lower risk, but effective screening and timely treatment remain essential for people who develop disease.

Geography adds another layer of complexity. Eastern China recorded the highest lifetime incidence risk in the analysis, at 13.42%, while lower risks were observed in the Northwestern region. These differences may reflect a combination of socioeconomic conditions, urbanization, dietary patterns, occupational exposures, health behaviors, population age structures, infection prevalence and access to diagnostic services. Higher recorded incidence can sometimes indicate not only greater underlying disease risk but also more complete detection through screening and medical care. Conversely, lower reported risk does not necessarily mean that cancer is absent; limited access to diagnosis or differences in registration may affect estimates. Even with these limitations, the regional variation shows why national averages cannot fully guide prevention planning.

The concept of remaining lifetime risk provides a further warning for health systems. According to the analysis, risk rises most sharply after the age of 40, creating an important period for prevention and early detection. Screening is not a universal intervention that should be applied identically to every person, and the appropriate age, test and interval depend on national guidelines, personal risk and available medical resources. However, colorectal screening can identify precancerous polyps or cancers at earlier, more treatable stages, while evaluation for gastric disease may be particularly relevant in populations with elevated risks. Prevention can also begin before screening through vaccination against hepatitis B, testing and treatment for relevant infections, tobacco cessation, moderation of alcohol intake, healthy diets, regular physical activity and control of obesity. The study’s age-specific findings can help policymakers determine where these measures may have the greatest effect.

The researchers describe their results as a national and regional “survival atlas” for a country undergoing a profound demographic and epidemiological transition. The value of the analysis lies not only in the headline figure of one in nine, but also in the way it connects statistical modeling with decisions about health insurance, screening capacity, cancer registries and community-based prevention. A precision-based strategy could direct more intensive screening and public-health resources toward regions and populations with higher estimated risks, while strengthening basic prevention and diagnosis nationwide. Such an approach would also need to address disparities in access to endoscopy, pathology, surgery, radiotherapy, systemic treatment and long-term follow-up.

The findings carry significance beyond China. Many rapidly developing countries are experiencing a similar shift from infection-associated cancers toward cancers linked to aging, metabolic disease, dietary change and sedentary behavior, even as older risks remain. The Chinese experience demonstrates that cancer control must evolve as societies do. Lifetime-risk estimates can make that evolution visible, helping governments move beyond short-term incidence counts toward planning that reflects the full duration of human life. The study does not suggest that digestive cancer is inevitable, nor that a single intervention can reverse the trend. It shows instead that the burden is measurable, unevenly distributed and potentially modifiable. With earlier detection, stronger infection control, healthier environments and more precisely targeted prevention, the probability represented by the “one-in-nine” estimate could become a starting point for reducing future deaths rather than a fixed forecast.

Subject of Research: People

Article Title: National and regional lifetime risks of developing and dying from digestive system cancers in China: findings of the Global Burden of Disease Study 2023

News Publication Date: 3-Jun-2026

Web References: https://doi.org/10.1097/CM9.0000000000004115

References: Zhou Maigeng, Qian Mao et al., “National and regional lifetime risks of developing and dying from digestive system cancers in China: findings of the Global Burden of Disease Study 2023,” Chinese Medical Journal, DOI: 10.1097/CM9.0000000000004115

Image Credits: Dr. Maigeng Zhou, National Center for Chronic and Noncommunicable Disease Control and Prevention, China

Keywords: Digestive system cancer, colorectal cancer, lifetime risk, China, Global Burden of Disease Study 2023, cancer epidemiology, cancer prevention, cancer screening, public health, AMP method

Tags: China CDC digestive cancer statisticsChina digestive cancer lifetime riskcolorectaldigestive cancer epidemiology in Chinaglobal burden of digestive system cancersimpact of regional factors on digestive cancer risklifetime cancer mortality estimates in Chinaliver cancer risk in Chinalong-term cancer risk assessment in Chinese populationregional differences in digestive cancer mortality ratesregional variation in digestive cancer risk in Chinasignificance of lifetime risk analysis for cancer preventionstomach